This federal contract award, valued at $14,409.02, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of an ATM unit for probe Z151032/0001, with a completion date of September 30, 2023. The contract type is a Purchase Order with a Firm Fixed Price pricing structure. This award was not designated as a set-aside contract. Bruker Corporation is a global scientific...
The Department of Health and Human Services' National Institute of Diabetes and Digestive and Kidney Diseases awarded a $15,514 firm fixed-price purchase order to Bruker Biospin Corp. for an AQS REFERENCE BOARD/3 1200. Bruker Biospin Corp. is a subsidiary of Bruker Corporation located in Billerica, Massachusetts. The order is to be completed by September 30, 2023 in support of NIDDK programs. No set-aside designation or subcontractors were identified. The award provides the research equipment...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,855,935.00 firm-fixed-price contract to Bruker Biospin Corp, a for-profit manufacturer, to provide five Avance Neo consoles for Bruker NMR spectrometers, a Q-band pulse 300 W amplifier for a Q-band pulsed EPR spectrometer, and two cryoplatforms for Bruker NMR spectrometers. This award supports upgrading the NMR and EPR...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, to acquire a service contract for a CryoPlatform system. The $216,845.10 contract will be performed in Billerica, Massachusetts and has an ultimate completion date of September 27, 2023. The contract was awarded on September 28, 2022, and did not utilize any set-aside designations. The original...
This federal contract award, valued at $14,409.02, was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of an Automated Tube Measurement (ATM) module for an NIH probe. This purchase order is a firm fixed-price contract with a completion date of November 1, 2023. The award did not utilize any set-aside designations. Bruker Biospin Corp is a manufacturer of scientific...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $230,346.00 firm-fixed-price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments. The contract is for the provision of an NMR accessory MAS probe. The place of performance is Bethesda, Maryland. The contract does not have a set-aside designation. Bruker Biospin Corp is a subsidiary of the Bruker...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments. The $76,869.48 firm fixed-price purchase order is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and support services. The award does not have a set-aside designation. Bruker Biospin Corp has a history of providing specialized equipment and services to various U.S....
This federal contract award, valued at $39,000.00, was issued by the National Institute on Drug Abuse (NIDA) to Bruker Biospin Corp for maintenance services on Bruker's scientific instruments. The contract is a Firm Fixed Price Purchase Order with a completion date of September 29, 2012. Bruker Biospin Corp is a subsidiary of the larger Bruker Corporation, which is a global provider of scientific instrumentation and analytical technologies to government agencies. Bruker has received numerous...
This is a $216,140.00 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a wholly-owned subsidiary of Bruker Corporation. The contract is for the delivery of a MARIUS CLORE IN 5/B1-301ER 4118HVCF5L FLEXLINE CRYOGEN-FREE VTSYSTEM, which is a specialized nuclear magnetic resonance (NMR) spectrometer system. The award does not utilize any set-aside designations. Bruker Biospin Corp is an established...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $216,684 firm-fixed price purchase order to Bruker Biospin Corp. for a CryoPlatformTM Maintenance Agreement. This agreement will provide critical maintenance services for the agency's Nuclear Magnetic Resonance (NMR) spectrometers used in protein research. Bruker Biospin Corp. is the sole source provider of the proprietary CryoPlatform equipment and authorized maintenance services. This purchase order does...
This federal contract award, valued at $440,500.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a manufacturer of scientific instruments. The award is for the purchase of an AVANCE III HD 600 console, as described in the associated quote. The end user is Gideon Clore, and the contract does not have a set-aside designation. Bruker Biospin Corp is known to provide nuclear magnetic resonance spectrometers, upgrades, maintenance, and support services to various federal agencies, including the National Institutes of Health, Food and Drug Administration, and Department of Defense, among others. This contract award is for the delivery and installation of the specified equipment at the NIDDK facility in Billerica, Massachusetts.